Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Human Male Subjects”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03555890
What this trial is testing

Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT)

Who this might be right for
Rhinitis
GlaxoSmithKline 72
Early research (Phase 1)Study completedNCT05657613
What this trial is testing

Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects

Who this might be right for
Drug Interactions
CTI BioPharma 60
Early research (Phase 1)Study completedNCT04534582
What this trial is testing

Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects

Who this might be right for
Healthy Male Volunteers
Shanghai Henlius Biotech 252
Early research (Phase 1)Study completedNCT02055716
What this trial is testing

Sulforadex in Healthy Human Males MAD

Who this might be right for
Prostate Cancer
Evgen Pharma 18
Early research (Phase 1)Study completedNCT04531150
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects

Who this might be right for
Pharmacokinetic
Inversago Pharma Inc. 40
Early research (Phase 1)Study completedNCT01967589
What this trial is testing

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 82
Early research (Phase 1)UnknownNCT05491460
What this trial is testing

Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects

Who this might be right for
Anticoagulant Therapy
Doasense GmbH 24
Early research (Phase 1)Study completedNCT05439148
What this trial is testing

OPC-61815 in Healthy Chinese Male Subjects

Who this might be right for
Healthy Adult Male
Otsuka Beijing Research Institute 18
Early research (Phase 1)Study completedNCT04984707
What this trial is testing

Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration

Who this might be right for
Androgenetic Alopecia
Suzhou Kintor Pharmaceutical Inc, 40
Early research (Phase 1)Study completedNCT02835508
What this trial is testing

Pharmacokinetic Study of JNJ-56021927 When Taken Orally as Tablet Formulation in Healthy Male Japanese Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 18
Early research (Phase 1)Study completedNCT00761540
What this trial is testing

To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 37
Early research (Phase 1)Study completedNCT03007810
What this trial is testing

Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects

Who this might be right for
Psoriasis
Tianjin Hemay Bio-Tech Co., Ltd 68
Early research (Phase 1)Study completedNCT05275010
What this trial is testing

A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System

Who this might be right for
Healthy Male Subjects
Hoffmann-La Roche 151
Not applicableStudy completedNCT06908395
What this trial is testing

Impact Of Everyday Light Exposure Patterns On Health

Who this might be right for
Healthy Male and Female SubjectsHealthy Elderly
RWTH Aachen University 62
Early research (Phase 1)Study completedNCT02266511
What this trial is testing

Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride in Healthy Male Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 30
Early research (Phase 1)Study completedNCT02341599
What this trial is testing

Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001)

Who this might be right for
Healthy VolunteersRenal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 40
Early research (Phase 1)Study completedNCT07185113
What this trial is testing

Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects

Who this might be right for
Healthy Adult Male
GEn1E Lifesciences 6
Not applicableStudy completedNCT01080586
What this trial is testing

Bioequivalence Study of Cyclosporine 100mg Capsule Under Fed Condition

Who this might be right for
Healthy Volunteers
Panacea Biotec Ltd 36
Very early researchStudy completedNCT05200169
What this trial is testing

Mass Balance Recovery, Metabolite Profile and Metabolite Identification of 14C-AB1010 in Healthy Male Subjects

Who this might be right for
Healthy Volunteers
AB Science 4
Early research (Phase 1)Study completedNCT01451775
What this trial is testing

Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.

Who this might be right for
Healthy
Boehringer Ingelheim 18
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation